MSAM
ZBH icon

Moloney Securities Asset Management’s Zimmer Biomet ZBH Stock Holding History

Moloney Securities Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,394
Closed -$452K – 376
2019
Q3 		$452K Buy
+3,394
New +$438K 0.15% 167

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Moloney Securities Asset Management's ZBH Position: Q4 2019 in Review

Moloney Securities Asset Management sold out of Zimmer Biomet (ZBH) in Q4 2019, closing a stake of 3,394 shares — an estimated $452K sold.

Moloney Securities Asset Management first reported a position in ZBH in Q3 2019 and held it in 1 quarter. The position peaked at $452K in Q3 2019. 989 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

  • Moloney Securities Asset Management reported no remaining Zimmer Biomet position as of Q4 2019 after selling out during the quarter.
  • Moloney Securities Asset Management sold 3,394 Zimmer Biomet shares in Q4 2019, an estimated $452K.
  • Moloney Securities Asset Management first reported a position in Zimmer Biomet in Q3 2019 and held it in 1 quarter.
  • Moloney Securities Asset Management's Zimmer Biomet position peaked at $452K in Q3 2019.
  • 989 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on Moloney Securities Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.